Recommendations for Prenatal Echocardiography: A Report from International Prenatal Cardiology Collaboration Group.

Open access

Abstract

International Prenatal Cardiology Collaboration Group (IPCCG) links specialists from prenatal cardiology all over the world. In this recommendation we would like to focus on the fetal/prenatal echocardiography official report. So far many recommendations focused mainly on technical aspects of the fetal heart examination.

1. Sklansky M.S. Current guidelines for fetal echocardiography: time to raise the bar. J Ultrasound Med. 2011; 30: 284-286.

2. Nelle M, Raio L, Pavlovic M, Carrel T, Surbek D, Meyer-Wittkopf M. Prenatal diagnosis and treatment planning of congenital heart defects-possibilities and limits. World J Pediatr. 2009; 5: 18-22.

3. Słodki M., Zych-Krekora K., Axt-Fliedner R., [et al.]. The International Prenatal Cardiology Collaboration Group- a new concept for global research study. Journal of Ultrasonography. 2016; 16: 94-96.

4. Lee W., Allan L., Carvalho JS., [et al]. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008; 32: 239-242.

5. International Society of Ultrasound in Obstetrics and Gynecology. Cardiac screening guidelines of the fetus: guidelines for performing the ‘basic’ and ‘extended basic’ cardiac scan. Ultrasound Obstet Gynecol 2006; 27: 107-113.

6. Slodki M., Respondek-Liberska M. Proposal of screening fetal heart examination from granted by Polish Ministry of Health Program Kardio- Prenatal 2008. Ginekol Pol. 2009; 80: 466-470.

7. Polish Gynecological Society-Ultrasound Section Guidelines on ultrasound screening in uncomplicated pregnancy- 2015. Ginekol Pol. 2015; 7: 551-559.

8. Respondek-Liberska M., Janiak K. Fetal echocardiography protocol for reference centers. Polski Przegląd Kardiologiczny. 2010; 12: 212-218.

9. American Institute of Ultrasound in Medicine. AIUM Practice Parameter for the Performance of Fetal Echocardiography. American Institute of Ultrasound in Medicine website.www.aium.org. 2013: http://www.aium.org/resources/guidelines/fetalecho.pdf

10. Respondek-Liberska M., Sklansky M., Wood D., [et al.]. Recommendations for fetal echocardiography in singleton pregnancy in 2015. Prenat Cardio. 2015; 5: 28-34.

11. Wood D, Respondek-Liberska M, Puerto B, Weiner S. Perinatal echocardiography: protocols for evaluating the fetal and neonatal heart. J. Perinat. Med. 2009; 37: 5-11.

12. Donofrio MT, Moon-Grady AJ, Hornberger LK, [et al.]. Diagnosis and treatment of fetal cardiac disease. A scientific statement from the American Heart Association. Circulation. 2014; 129: 2183-2242.

13. Sklansky M., De Vore G. R. Fetal cardiac screening. What are we and our guidelines doing wrong?J Ultrasound Med. 2016; 35: 679-681.

14. Detterich JA, Pruetz J, Sklansky MS. Color M-mode sonography for evaluation of fetal arrhythmias. J Ultrasound Med. 2012; 31: 1681-1688.

15. Sklansky M.S. Prenatal screening for congenital heart disease. A moving proposal. J Ultrasound Med. 2007; 26: 1-3.

16. Słodki M., Respondek-Liberska M. New classifications of prenatally diagnosed congenital heart defects and their influence on neonatal survivability. Prenat Cardio. 2015; 5: 6-8.

17. Wood D. Evaluating the fetal heart: how do we improve? Prenat Cardio. 2013; 3: 5-8.

18. Huhta JC, Paul JJ. Doppler in fetal heart failure. Clin Obstet Gynecol. 2010; 53: 915-929.

19. Respondek-Liberska M. Fetal thymus- review. Prenat Cardio. 2014; 4: 9-12.

20. Respondek-Liberska M., Sokołowski Ł. Słodki M, [et al.]. Prenatal diagnosis of TAPVC on Monday, delivery of Tuesday and cardiac surgery at Wednesday- a model of perinatal care in 3rd trimester in case of fetal/ neonatal critical heart defect in tertiary center. Prenat Cardio. 2016; 6: 37-42.

21. Strzelecka I., Płużańska J, Węgrzynowski, J, [et al.]. Routine third trimester cardiac evaluation: time for consideration. Prenat Cardio. 2015; 5: 18-23.

22. Hua M., Weiner S. Maternal conditions affecting the fetal heart. Prenat Cardio. 2013; 3: 5-11.

23. Respondek-Liberska M. Atlas of fetal heart defects. Wyd. ADI 2011

24. Słodki M. Habilitation Thesis. Medical University Lodz, PWSZ Plock: Poland,2012, https://www.researchgate.net/publication/291337775_Prenatal_and_perinatal_management_for_pregnant_women_with_fetal_cardiac_defects_based_on_new_prenatal_cardiac_anomalies_classification_Polish.

25. Donofrio MT, Levy RJ, Schuette JJ, [et al.]. Specialized delivery room planning for fetuses with critical congenital heart disease. Am J Cardiol 2013; 111(5): 737-747.

26. Pruetz JD, Carroll C, Trento LU, [et al.]. Outcomes of critical congenital heart disease requiring emergent neonatal cardiac intervention. Prenat Diagn 2014; 34(12): 1127-1132.

27. Słodki M., Respondek-Liberska M. Pruetz JD, Donofrio MT. Fetal cardiology: changing the definition of critical heart disease in the newborn. Journal of Perinatology. 2016: 1-6.

28. Divanović A, Hor K, Cnota J, [et al.]. Prediction and perinatal management of severely restrictive atrial septum in fetuses with critical left heart obstruction: clinical experience using pulmonary venous Doppler analysis. J Thorac Cardiovasc Surg 2011; 141: 988-994.

29. Słodki M, Axt-Fliedner R, Zych-Krekora K, [et al.]. International Prenatal Cardiology Collaboration Group. A new method to predict the need for a Rashkind procedure in fetuses with dextro-transposition of the great arteries. Ultrasound Obstet Gynecol. 2017 Mar 14. doi:

30. Ganesan S, Brook MM, Silverman NH, Moon-Grady AJ. Prenatal findings in total anomalous pulmonary venous return: a diagnostic road map starts with obstetric screening views. J Ultrasound Med 2014; 33(7): 1193-1207.

31. Strzelecka I, Respondek-Liberska M, Słodki M, [et al.]. Transplacental digoxin treatment In prenatal cardiac problems in singleton pregnancies- metaanalysis (based on literature: 1992-2015). Prenat Cardio. 2016; 6 (1): 67-74.

32. Channing A, Szwast A, Natarajan S, [et al.]. Re: Maternal hyperoxygenation improves left heart filling in fetuses with atrial septal aneurysm causing impendiment to left ventricular inflow. Ultrasound Obstet Gynecol. 2015; 45: 629-630.

33. Rasanen J, Wood DC, Debbs RH, [et al.]. Reactivity of the human fetal pulmonary circulation to maternal hyperoxygenation increases during the second half of pregnancy: a randomized study. Circulation. 1998; 97: 257-262.

34. Szwast A, Tian Z, Natarajan S, [et al.]. Vasoreactive response to maternal hyperoxygenation un the fetus with hypoplastic left syndrome. Circ Cardiovasc Imaging. 2010; 3: 172-178.

35. Kohl T. Chronic intermittent materno-fetal hyperoxygentaion in late gestation may improve on hypoplastic cardiovascular structures associated with cardiac malformations in human fetuses. Pediatr Cardiol. 2010; 31: 250-263.

36. Enzensberger C, Axt-Fliedner R, Degenhardt J, [et al.]. M. Pulmonary Vasoreactivity to Materno-Fetal Hyperoxygenation Testing in Fetuses with Hypoplastic Left Heart. Ultraschall Med. 2016; 37: 195-200.

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 251 251 18
PDF Downloads 101 101 16